Zacks Investment Research upgraded shares of ICU MEDICAL INC (ICUI) from NEUTRAL to OUTPERFORM on October 19, 2012, with a target price of $64.90.
ICU Medical, Inc., together with its wholly-owned subsidiary Budget Medical Products, Inc. is a leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in intravenous therapy applications. The company's intravenous connectors are designed to prevent accidental disconnection's of intravenous lines and to protect healthcare workers and their patients from the spread of infectious diseases such as Hepatitis B and Human Immunodeficiency Virus by significantly reducing the risk of accidental needlesticks.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on ICU MEDICAL INC (ICUI),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment